Xeris Pharmaceuticals has teamed up with the American Diabetes Association (ADA) to raise awareness of the importance of ...

DPP-4 inhibitors improve your blood sugar without making it drop too low alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), and sitagliptin (Januvia) glucagon-like peptides ...

Most of this rise was associated with the expansion of the sales force for recently purchased BAQSIMI. Revenues rose nearly six percent on a year-over-year basis to $191.2 million, some $3 million ...

It isn’t known whether Baqsimi (glucagon) is safe to use while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine ...

Insulin resistance is a condition where the body's cells become less responsive to insulin, leading to higher blood sugar levels. One of the key indicators of insulin resistance is mean fasting blood ...